Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
STABLE PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
No-Receipt date
2018-01608 - 10/05/2018
No-Filing date
20180401284 - 10/05/2018
No-Granting date
3095988 - 13/06/2018
No-EPO application date
13733789.5 - 04/01/2013
No-EPO granting date
2800558 - 11/04/2018
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2018 - 12/10/2018
Expiration date
05/01/2033
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
KR2012000195406/01/2012/KR
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/4704
A61K 31/495
A61K 31/496
A61K 31/4965
A61K 47/12
A61K 9/14
A61K 9/20
A61K 9/28
A61K 9/48
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
889320
HANMI PHARM. CO., LTD.
214 MUHA-RO PALTAN-MYEON
HWASEONG-SI, GYEONGGI-DO 445-958
SOUTH KOREA
Inventors
Code
Firstname
Surname
2212254
KWON, TAEK KWAN
2212255
KIM, DONG HO
2212256
KIM, KYEONG SOO
2212257
KIM, YONG IL
2212258
PARK, JAE HYUN
2212259
WOO, JONG SOO
Representatives
Code
Firstname
Surname
Address
Town
Zip
3554
ANTHOULA
GALANOPOULOU
DIONYSOU 68
MAROUSI (ATTIKIS)
15124
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2897
ALKISTIS-EIRINI
MALAMI
SKOUFA 52
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
8/5/2021 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 07/2021 Αρ. Πρωτ. ΓΔ 1464 / 05.08.2021
Payments history
8 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).